Faculty

Charanjit S. Rihal, M.D.

Clinical Studies

SAPIEN M3 System TransCatheter MItral Valve ReplaCement via TransseptaL AccEss Rochester, Minn.
The purpose of this study is to establish the safety and effectiveness of the SAPIEN M3 System in subjects with mitral regurgitation (MR) who are at high surgical risk.

Evaluation of Perivalvular Leak Repair Rochester, Minn.
The aim of this study is to determine that percutaneous repair of paravavular defect has improved clinical outcomes, survival, reduced the incidence of hemolysis related to the paravalvular leak, and that percutaneous intervention has reduced the overall need for surgical intervention.

Continued Access to PREVAIL (CAP2)- WATCHMAN Left Atrial Appendage (LAA) Closure Technology (CAP2) Rochester, Minn.
To provide additional information about the safety and efficacy of the WATCHMAN LAA Closure Technology.
Genetic Causes of Stent Thrombosis Rochester, Minn.
The purpose of this study is to identify novel genetic variants associated with stent thrombosis.
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE) (PRELUDE) Rochester, Minn.
The purpose of this study is to assess the safety and performance of the Caisson Interventional Transcatheter MitralValve Replacement (TMVR) system for the treatment of severe symptomatic MitralValve Regurgitation (MR).